glp 1 and digestion Understanding GLP-1 receptor agonists their impact on drug discovery What are GLP-1 Receptor Agonists?

The role of glucagon-like peptide 1 receptor agonists in alcohol use disorder

Low-dose aspirin upregulates tyrosine hydroxylase and increases dopamine production in dopaminergic neurons: implications for Parkinson's disease

Hrickova et al., 2024

Clinical trials for the newest GLP-1 medications showed participants lost an average of 24-29% of their body weight over 1218 months

A 2024 study from the International Foundation of Employee Benefit Plans showed that employer coverage of GLP-1s is still limited, with 34% of corporate plans currently providing coverage for non-diabetic patients who want to lose weight (up 8 percentage points from 2023)

dot plots and histograms were used to visualize data